Expertise in
14
conditions

Martin J. Schlumberger

Gustave Roussy
Villejuif, FR 
Expertise in
14
conditions
Gustave Roussy
Villejuif, FR 

Overview

Martin Schlumberger practices practicing medicine in Villejuif, France.

Mr. Schlumberger is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Medullary Thyroid Carcinoma, Neuroendocrine Tumor, Thyroidectomy, and Hormone Replacement Therapy (HRT).

He is actively involved in clinical research, co-authoring 244 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Gustave Roussy
Villejuif, 94805, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
A Randomized, Multicenter, Open-label, Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
Enrollment Status: Completed
Publish Date: July 02, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA™; SAR390530 (Formerly AstraZeneca ZD6474)) 300 mg in Patients With Differentiated Thyroid Cancer That Is Either Locally Advanced or Metastatic Who Are Refractory or Unsuitable for Radioiodine (RAI) Therapy
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA™; SAR390530 (Formerly AstraZeneca ZD6474)) 300 mg in Patients With Differentiated Thyroid Cancer That Is Either Locally Advanced or Metastatic Who Are Refractory or Unsuitable for Radioiodine (RAI) Therapy
Enrollment Status: Completed
Publish Date: July 23, 2024
Intervention Type: Drug
Study Drug: Vandetanib
Study Phase: Phase 3
First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma (PPGL)
Enrollment Status: Completed
Publish Date: August 04, 2022
Intervention Type: Drug
Study Drug: Sunitinib
Study Phase: Phase 2
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Utility of Recombinant Human Thyrotropin (rTSH) PET-CT Fusion Scanning to Identify Residual Well-differentiated Epithelial Thyroid Cancer
Enrollment Status: Completed
Publish Date: November 02, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

244 Total Publications

Rethinking prophylactic central neck dissection in clinically node-negative papillary thyroid cancer.
Rethinking prophylactic central neck dissection in clinically node-negative papillary thyroid cancer.
Journal: The lancet. Diabetes & endocrinology
Published: February 23, 2026

Frequently Asked Questions about Martin J. Schlumberger

Is Martin J. Schlumberger a top-rated expert for Thyroid Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Martin J. Schlumberger is classified as an Elite expert for Thyroid Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Martin J. Schlumberger participate in research or clinical trials?

Yes. Martin J. Schlumberger has published 244 articles and abstracts on conditions like Thyroid Cancer. You can view a list of Martin J. Schlumberger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schlumberger's expertise for a condition
ConditionClose
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile